An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Vicarious Surgical to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) will engage in a fireside chat at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 16 at 4:00 p.m. Eastern Time. The company focuses on enhancing surgical procedures through next-generation robotic technology, which has been recognized by the FDA with a Breakthrough Device Designation. Founded in 2014, Vicarious Surgical aims to improve patient outcomes while reducing healthcare costs. The event is accessible via BTIG representatives.
Positive
None.
Negative
None.
WALTHAM, Mass.--(BUSINESS WIRE)--
Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both cost and efficiency of surgical procedures, today announced the company will participate in a fireside chat at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.
Management is scheduled to present on February 16 at 4:00 p.m. Eastern Time. To listen to the live event, please contact your BTIG representative with interest.
About Vicarious Surgical
Founded in 2014, Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goals of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. The Company’s novel surgical approach uses proprietary human-like surgical robots to transport surgeons inside the patient to perform minimally invasive surgery. The Company’s technology was granted Breakthrough Device Designation by the FDA, and Vicarious Surgical believes the Vicarious System is the first surgical robot to receive this designation from the FDA. The Company is led by an experienced team of technologists, medical device professionals and physicians, and is backed by technology luminaries including Bill Gates, Vinod Khosla’s Khosla Ventures, Innovation Endeavors, Jerry Yang’s AME Cloud Ventures, Sun Hung Kai & Co. Ltd and Philip Liang’s E15 VC. The Company is headquartered in Waltham, Mass. Learn more at www.vicarioussurgical.com.
When will Vicarious Surgical participate in the BTIG conference?
Vicarious Surgical will participate in the BTIG conference on February 16 at 4:00 p.m. Eastern Time.
What is the focus of Vicarious Surgical's technology?
Vicarious Surgical focuses on enhancing the efficiency of surgical procedures and improving patient outcomes through next-generation robotic technology.
What recognition has Vicarious Surgical's technology received?
Vicarious Surgical's technology received Breakthrough Device Designation from the FDA.
What is the stock symbol for Vicarious Surgical?
The stock symbol for Vicarious Surgical is RBOT, with an associated warrant symbol RBOT WS.
How can I listen to the Vicarious Surgical presentation at the BTIG conference?
To listen to the Vicarious Surgical presentation, please contact your BTIG representative.
